Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 91

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 91
---
                                 |     | —             |        |     | —                 |           |     |                | 13,800 |     | $              | 1,717,629 |
| Executive Vice President,                     |     |               |        |     |                   |           |     |                |        |     |                |           |
| Chief Customer Officer                        |     |               |        |     |                   |           |     |                |        |     |                |           |
| Former Officer                                |     |               |        |     |                   |           |     |                |        |     |                |           |
| Ryan E. Brown                                 |     |               |        |     |                   |           |     |                |        |     |                |           |
| Former Executive Vice President,              |     |               | 23,500 |     | $                 | 2,322,740 |     |                | 13,643 |     | $              | 1,697,548 |
| Chief General Counsel and Corporate Secretary |     |               |        |     |                   |           |     |                |        |     |                |           |

(1) Represents the stock price on the date of exercise minus the option exercise price multiplied by the number of shares acquired on exercise. (2) Represents the shares of our common stock acquired upon the vesting of RSUs and PSUs during 2024.

<div align='center'>64</div>

(3) For RSUs and PSUs, the value realized on vesting represents the closing price per share of our common stock on the vesting date multiplied by the number of shares that vested. 2024 Pensio n Benefits During 2024, none of our named executive officers were entitled to pension benefits or other payments of benefits pursuant to any plan following retirement. 2024 Nonqualified De ferred Compensation During 2024, none of our named executive officers were entitled to benefits under any nonqualified defined contribution or nonqualified deferred compensation plans.

Pay versus Performance Disclosure

In accordance with rules adopted by the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the following disclosure regarding “Compensation Actually Paid,” as determined by SEC rules for our principal executive officer (“PEO”) and Non-PEO NEOs and Company performance for the fiscal years listed below. The compensation committee did not consider the pay versus performance disclosure below in making its pay decisions for any of